BCAR3 Antikörper (C-Term)
Kurzübersicht für BCAR3 Antikörper (C-Term) (ABIN184592)
Target
Alle BCAR3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- C-Term
-
Verwendungszweck
- BCAR3
-
Sequenz
- RKLEPPPVKQ AEL
-
Kreuzreaktivität
- Rind (Kuh), Hund, Human, Schwein
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Immunogen
- Peptide with sequence C-RKLEPPPVKQAEL, from the C Terminus of the protein sequence according to NP_003558.1.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 110 kDa band observed in Mouse embryonic Kidney epithelial cell lysates (calculated MW of 92.6 kDa according to Human NP_003558.1) and 92.3 kDa according to Mouse NP_038895.1. Recommended concentration: 0.5-2 μg/mL. Data kindly provided
Peptide ELISA: antibody detection limit dilution 1:32000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- BCAR3 (Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
-
Andere Bezeichnung
- BCAR3
-
Hintergrund
- BCAR3, NSP2, SH2D3B, breast cancer anti-estrogen resistance 3, KIAA0554, OTTHUMP00000011961, breast cancer antiestrogen resistance 3, dJ1033H22.2 (breast cancer anti-estrogen resistance 3)
-
Gen-ID
- 8412
-
NCBI Accession
- NP_003558
Target
-